Andrew McKibben
SVP of Strategic Finance and Investor Relations
Replay available
Mirum Pharmaceuticals, Inc. (MIRM) Q1 2026 Earnings Call
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) Q1 2026 earnings conference call, held 2026-05-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Chris Peets
Chief Executive Officer
Peter Radovich
President and Chief Operating Officer
Eric Bierkhold
Chief Financial Officer
Joanne Kwan
Chief Medical Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Mirum Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:06.063 Good afternoon and welcome to Merum Pharmaceuticals' first quarter 2026 earnings 00:00:06.063 -- 00:00:10.111 conference call. My name is Tracy and I will be your operator today. 00:00:10.111 -- 00:00:15.281 All lines are currently in a listen-only mode and there will be an opportunity for Q&A 00:00:15.281 -- 00:00:19.689 after management's prepared remarks. If you would like to ask a question during that 00:00:19.689 -- 00:00:24.765 time, press star 1 to raise your hand. I would now like to hand the call, the 00:00:24.765 -- 00:00:30.573 conference over to Andrew McKibben, SVP of Strategic Finance and Investor Relations. 00:00:30.573 -- 00:00:32.917 Please go ahead. 00:00:32.917 -- 00:00:35.400 Thank you, Tracy, and good afternoon, everyone. 00:00:35.400 -- 00:00:39.486 I'd like to welcome you to Miriam Pharmaceuticals' first quarter 2026 earnings conference 00:00:39.486 -- 00:00:43.872 call. For our prepared remarks, I'm joined today by our Chief Executive Officer, Chris 00:00:43.872 -- 00:00:48.238 Peets, our President and Chief Operating Officer, Peter Radovich, and Eric Bierkhold, 00:00:48.238 -- 00:00:52.132 our Chief Financial Officer. Our chief medical officer, Joanne Kwan, will be joining 00:00:52.132 -- 00:00:56.496 us for Q&A. Earlier this afternoon, Merim issued a press release reporting our first 00:00:56.496 -- 00:01:01.842 quarter 2026 financial results. Copies of the press release and our SEC filings are available 00:01:01.842 -- 00:01:05.786 in the investor section of our website. Before we start, I'd like to remind you that 00:01:05.786 -- 00:01:09.651 during the course of this conference call, we'll be making certain forward-looking statements 00:01:09.651 -- 00:01:14.276 based on management's current expectation...